Aerie's Rhopressa wins FDA panel votes

By Allison Johnson | Oct 13, 2017 | 9:41 PM GMT

An FDA advisory committee voted 9-1 on Friday that the efficacy of Rhopressa netarsudil 0.02% from Aerie Pharmaceuticals Inc. (NASDAQ:AERI) shown in clinical